It seems we can’t find what you’re looking for. Perhaps searching can help.
1843 - 2030
London Health Sciences Centre – (SIENDO) A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer